* Core Laboratories Inc reported quarterly adjusted earnings of 19 cents per share for the quarter ended in March, identical to the same quarter last year. The mean expectation of eight analysts for the quarter was for earnings of 16 cents per share. Wall Street expected results to range from 15 cents to 17 cents per share.
* Revenue rose 1% to $129.64 million from a year ago; analysts expected $124.44 million.
* Core Laboratories Inc's reported EPS for the quarter was 7 cents.
* Core Laboratories Inc shares had fallen by 0.5% this quarter and lost 3.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 22.1% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 6 "hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the business support services peer group is also "hold"
Wall Street's median 12-month price target for Core Laboratories Inc is $17.50 This summary was machine generated from LSEG data April 24 at 11:08 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.16 0.19 Beat
Dec. 31 2023 0.19 0.19 Met
Sep. 30 2023 0.22 0.22 Met
Jun. 30 2023 0.20 0.21 Beat
Comments